Abstract 4427: LS007, a potent and orally bioavailable CDK9 inhibitor, suppresses the growth of triple-negative and estrogen receptor-positive breast cancer von Rahaman, Muhammed Hamidur, Zhang, Yinghui, Islam, Md Saiful, Heinemann, Gary, Anshabo, Abel Tesfaye, Albrecht, Hugo, Milne, Robert, Wang, Shudong

Volltext